Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease
- 1 May 2016
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 89, 55-64
Abstract
No abstract availableKeywords
Funding Information
- Italian Ministry of University (RBIN047W33)
- Italian Society of Pharmacology
- Emilia-Romagna and Region Aquitaine cooperation project (2255/2010 and 2011/2589)
- University of Bordeaux
- Centre National de la Recherche Scientifique
- Agence Nationale de la Recherche (ANR-12-BSV4-0001-01, ANR-10-LABX-43 to E.B.)
This publication has 81 references indexed in Scilit:
- Identification of NIPSNAP1 as a Nocistatin-interacting Protein Involving Pain TransmissionJournal of Biological Chemistry, 2012
- Parkinson's disease and α‐synuclein expressionMovement Disorders, 2011
- MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neuronsNeuroscience, 2010
- Nociceptin/Orphanin FQ Receptor Activation Attenuates Antinociception Induced by Mixed Nociceptin/Orphanin FQ/μ-Opioid Receptor AgonistsThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned ratsNeuropharmacology, 2009
- Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonismNeurobiology of Disease, 2008
- Nocistatin inhibits 5‐hydroxytryptamine release in the mouse neocortex via presynaptic Gi/oprotein linked pathwaysBritish Journal of Pharmacology, 2007
- MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activityNeurobiology of Disease, 2007
- α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999